Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06413043
NA

Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy

Sponsor: All India Institute of Medical Sciences, Bhubaneswar

View on ClinicalTrials.gov

Summary

The Study on efficacy of add on selenium in mild-to-moderate Graves ophthalmopathy: A Randomized Control Trial.; The study aims to evaluate the response of adding selenium in patients with Graves ophthalmopathy, focusing on improving quality of life, CAS scoring, and thyroid status. The methodology involves a Randomized Control Trial with a sample size of 78 patients. Patients meeting specific criteria will receive either standard treatment with Anti Thyroid Drugs and Vitamin B complex or add on selenium with Vitamin B complex for 6 months. Outcome measures include CAS score reduction, thyroid function improvement, and quality of life enhancement. The study will last 18 months, with various investigations and ethical considerations outlined. The document emphasizes the importance of early diagnosis of Graves Ophthalmopathy to prevent vision loss and deformity, highlighting the significance of informed patients and healthcare professionals regarding TED symptoms and risk factors.

Official title: Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy: A Randomized Control Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

78

Start Date

2024-05-06

Completion Date

2025-11-05

Last Updated

2024-05-14

Healthy Volunteers

No

Interventions

DRUG

Selenium

Add on Selenium (100mcg once daily) with Vitamin B Complex and Standard Treatment for Grave's Disease

Locations (1)

AIIMS Bhubaneswar

Bhubaneswar, Odisha, India